The Valley Desk

NCT06868277 · Interventional trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Overall registry status Recruiting

Phase 3

Conditions Carcinoma, Non-Small Cell Lung

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov